v3.10.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2018
Mar. 31, 2018
Current assets    
Cash $ 4,824,901 $ 6,974,070
Accounts receivable 0 74,813
Prepaid expenses and other current assets 35,067 181,367
Total current assets 4,859,968 7,230,250
Property and equipment, net 9,669 27,552
Patents, net 68,959 75,832
Deposits 12,159 18,270
Total assets 4,950,755 7,351,904
Current liabilties    
Accounts payable 69,613 124,450
Due to related parties 69,750 90,366
Convertible notes payable, net 932,014 0
Other current liabilities 709,348 263,141
Total current liabilities 1,780,725 477,957
Convertible notes payable, net 0 841,153
Total liabilities 1,780,725 1,319,110
Commitments and Contingencies (Note 13)
Stockholders' Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized as of December 31, 2018 and March 31, 2018; 18,577,123 and 17,739,511 shares issued and outstanding as of December 31, 2018 and March 31, 2018, respectively 18,577 17,740
Additional paid-in capital 107,283,829 105,574,014
Accumulated deficit (104,010,327) (99,457,714)
Total Aethlon Medical, Inc. stockholders' equity before noncontrolling interests 3,292,079 6,134,040
Noncontrolling interests (122,049) (101,246)
Total stockholders' equity 3,170,030 6,032,794
Total liabilities and stockholders' equity $ 4,950,755 $ 7,351,904

Source